Affiliation:
1. Yonsei University College of Medicine
2. Chung-Ang University Graduate School
3. Seoul National University
Abstract
Abstract
The coronavirus disease 2019 (COVID-19) epidemic is a major public health problem worldwide. This study estimated the impact of SARS-CoV-2 in terms of the excess mortality from any cause during the COVID-19 epidemic in the Republic of Korea. The excess mortality during the COVID-19 epidemic was analyzed using the number of deaths over the past 5 years (2015–2019) in Korea. The numbers of total deaths and COVID-19–related deaths were counted from January 2020 through May 2022, using public data from the Korean Statistical Information Service (KOSIS) of Statistics Korea. These numbers were compared with nationwide mortality data from January 1, 2015, through December 2019. There were more than 24,000 reported deaths officially across Korea from January 2020 through May 2022. Excess mortality was observed nationwide in March, August, October, November, and December 2020; January, March, July, and August 2021; and October 2021 through May 2022, which was consistent with the epidemic waves in the country. After 2021, significant excess mortality occurred at the national level despite decreasing COVID-19 case fatality rates which means there might be an another relevant factors on all-cause mortality aside from the direct effect of deaths from COVID-19.
Publisher
Research Square Platform LLC
Reference26 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan;Huang C;China,2020
2. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak;Piccolo R,2020
3. COVID-19 collateral damage—psychological burden and behavioural changes among older adults during the first outbreak in Stockholm, Sweden: a cross-sectional study;Beridze G,2022
4. COVID-19 and excess mortality in the United States: A county-level analysis;Stokes AC;PLoS medicine.,2021
5. Investigating regional excess mortality during 2020 COVID-19 pandemic in selected Latin American countries;Lima EE;Genus.,2021